A detailed history of Tower Research Capital LLC (Trc) transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,155 shares of PYXS stock, worth $7,021. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,155
Holding current value
$7,021
% of portfolio
0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.83 - $3.94 $11,758 - $16,370
4,155 New
4,155 $15,000
Q1 2024

May 15, 2024

BUY
$2.03 - $6.59 $8,256 - $26,801
4,067 Added 72.12%
9,706 $41,000
Q4 2023

Feb 13, 2024

BUY
$1.4 - $2.09 $5,118 - $7,641
3,656 Added 184.37%
5,639 $10,000
Q3 2023

Nov 14, 2023

BUY
$1.6 - $2.78 $3,172 - $5,512
1,983 New
1,983 $3,000
Q1 2023

May 09, 2023

BUY
$1.38 - $6.0 $6,469 - $28,128
4,688 Added 75.88%
10,866 $43,000
Q4 2022

Feb 10, 2023

SELL
$1.14 - $2.0 $10,896 - $19,116
-9,558 Reduced 60.74%
6,178 $8,000
Q3 2022

Nov 10, 2022

BUY
$1.88 - $3.03 $23,830 - $38,408
12,676 Added 414.25%
15,736 $31,000
Q2 2022

Aug 15, 2022

BUY
$2.02 - $4.53 $882 - $1,979
437 Added 16.66%
3,060 $7,000
Q1 2022

May 12, 2022

BUY
$4.04 - $11.43 $7,918 - $22,402
1,960 Added 295.63%
2,623 $11,000
Q4 2021

Feb 14, 2022

BUY
$8.39 - $13.64 $5,562 - $9,043
663 New
663 $7,000

Others Institutions Holding PYXS

About Pyxis Oncology, Inc.


  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $59.3M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.